Reimbursable laboratory analyses
•
0 likes•89 views
Switzerland's official list of Reimbursable laboratory analyses: A case of desinvestment
Report
Share
Report
Share
Download to read offline
Recommended
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?
An Elicitation of Patients’ Preferences by Analytic Hierarchy Process (AHP)
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment
Jackie Tran, MD
University of Medicine and Dentistry of New Jersey, USA
HTAi 9th Annual Meeting, Bilbao
Integrated Care for a Patient Centered System
25 June, 2012
Health Technology Assessment (HTA) Report: Interventions to increase particip...
The document summarizes a Health Technology Assessment report on interventions to increase participation in organized cancer screening programs. It found that mail and phone recalls, as well as having a general practitioner's signature on the invitation letter, consistently increased participation. Fixed appointments also increased participation compared to open invitations. Self-sampling for HPV testing increased participation in non-responders relative to standard recall letters. The report evaluated interventions' efficacy, cost-effectiveness, organizational impact, and social/ethical issues.
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The document summarizes a presentation given at the HTAi Annual Meeting about the National Institute for Health and Care Excellence's (NICE) use of "colloquial evidence" in developing clinical guidance. It defines colloquial evidence, explores how NICE utilizes it alongside scientific evidence at different stages of the guidance process, and discusses developing better methods for identifying and critically appraising colloquial evidence. The presentation aims to map NICE's use of colloquial evidence to an existing conceptual framework and identify variations across NICE centers.
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ensure fair allocation of health care resources .
HTAi Conference 2012 Panel Session
Joint chairs
Professor Peter Littlejohns and Professor Albert Weale
Challenges in commissioning research on what works in integrated care
This document discusses challenges in commissioning research on integrated care and how new studies are tackling these challenges. Integrated care research is complex due to the interplay of context, mechanisms and outcomes, and difficulty tracking activity and costs across settings. New studies are using more robust methods like difference-in-difference analysis across multiple sites and person-linked data to better understand costs and impacts. They are also considering generalizability and using mixed methods to understand how micro-level integrated care can be supported at higher levels.
Building a portfolio of research findings for use by healthcare managers and ...
The document summarizes research conducted by the NIHR Health Services and Delivery Research programme on integrated care. It outlines several research projects funded through specific calls on integrated care between 2009-2011, including evaluations of case management initiatives, self-care support, and virtual wards. The research aims to identify healthcare managers' needs and generate evidence to improve services. The programme commissions applied health research to benefit the NHS based on both need and scientific merit.
Assessing the International Use
This document summarizes a study exploring methods for assessing international use of UK-funded health technology assessments (HTAs). The study reviewed literature on impact assessment models and explored bibliometrics, website analytics, and citations in HTA reports. Bibliometric analysis found low international academic impact. Website analytics revealed most non-UK visits were for systematic reviews. Citations in HTA reports provided some evidence of international uptake. The study recommends a multidimensional model and further research using case studies to explore nature of HTA use internationally.
Recommended
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?
An Elicitation of Patients’ Preferences by Analytic Hierarchy Process (AHP)
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment
Jackie Tran, MD
University of Medicine and Dentistry of New Jersey, USA
HTAi 9th Annual Meeting, Bilbao
Integrated Care for a Patient Centered System
25 June, 2012
Health Technology Assessment (HTA) Report: Interventions to increase particip...
The document summarizes a Health Technology Assessment report on interventions to increase participation in organized cancer screening programs. It found that mail and phone recalls, as well as having a general practitioner's signature on the invitation letter, consistently increased participation. Fixed appointments also increased participation compared to open invitations. Self-sampling for HPV testing increased participation in non-responders relative to standard recall letters. The report evaluated interventions' efficacy, cost-effectiveness, organizational impact, and social/ethical issues.
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The document summarizes a presentation given at the HTAi Annual Meeting about the National Institute for Health and Care Excellence's (NICE) use of "colloquial evidence" in developing clinical guidance. It defines colloquial evidence, explores how NICE utilizes it alongside scientific evidence at different stages of the guidance process, and discusses developing better methods for identifying and critically appraising colloquial evidence. The presentation aims to map NICE's use of colloquial evidence to an existing conceptual framework and identify variations across NICE centers.
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ensure fair allocation of health care resources .
HTAi Conference 2012 Panel Session
Joint chairs
Professor Peter Littlejohns and Professor Albert Weale
Challenges in commissioning research on what works in integrated care
This document discusses challenges in commissioning research on integrated care and how new studies are tackling these challenges. Integrated care research is complex due to the interplay of context, mechanisms and outcomes, and difficulty tracking activity and costs across settings. New studies are using more robust methods like difference-in-difference analysis across multiple sites and person-linked data to better understand costs and impacts. They are also considering generalizability and using mixed methods to understand how micro-level integrated care can be supported at higher levels.
Building a portfolio of research findings for use by healthcare managers and ...
The document summarizes research conducted by the NIHR Health Services and Delivery Research programme on integrated care. It outlines several research projects funded through specific calls on integrated care between 2009-2011, including evaluations of case management initiatives, self-care support, and virtual wards. The research aims to identify healthcare managers' needs and generate evidence to improve services. The programme commissions applied health research to benefit the NHS based on both need and scientific merit.
Assessing the International Use
This document summarizes a study exploring methods for assessing international use of UK-funded health technology assessments (HTAs). The study reviewed literature on impact assessment models and explored bibliometrics, website analytics, and citations in HTA reports. Bibliometric analysis found low international academic impact. Website analytics revealed most non-UK visits were for systematic reviews. Citations in HTA reports provided some evidence of international uptake. The study recommends a multidimensional model and further research using case studies to explore nature of HTA use internationally.
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPTANCE OF TELEMONITORING FOR CHRONIC PATIENTS
Estibalitz Orruño1, Marie-Pierre Gagnon2-3, José Asua4, Eva Reviriego1
1 Basque Office for Health Technology Assessment (Osteba), Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
2 Faculty of Nursing Sciences, Université Laval, Québec, Canada.
3 Research Centre of the Centre Hospitalier Universitaire de Québec, Québec, Canada.
4 Direction of Knowledge Management and Evaluation, Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
On the outside looking in.
The document discusses improving opportunities for patient and consumer engagement in health technology assessment (HTA) in Australia. It notes that while mechanisms exist for patient input, the overall HTA process is not well understood, advocacy groups are under-resourced, and the timeline for submissions is short. It proposes the formation of HTA_AUS, a coalition of interested parties including patient groups, government, industry and others, to address this issue and develop practical solutions like supporting patient submissions and extending deadlines. The coalition aims to increase awareness, education and support for patient engagement in HTA.
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATION: SOLUTIONS DEVELOPED IN THE IFEDH FRAMEWORK
G. Zauner
dwh Simulation Services
Vienna , Austria
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatments in France?
HTAi 2012, Bilbao
Clémence Thébaut, Olivier Scemama, Françoise Hamers, Catherine Rumeau-Pichon
Department of economic and public health evaluation
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual technology decision level part 2
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
The application of Health Technology Assessment in the field of biologics: an...
This document provides a health technology assessment of etanercept for treating rheumatoid arthritis. It includes 7 chapters that evaluate the epidemiology and burden of RA, biologic drugs for RA including etanercept, the economic impacts, organizational implications, and ethical considerations of using etanercept. The assessment finds that etanercept improves quality of life when combined with methotrexate compared to methotrexate alone, and has a cost-effectiveness ratio of €25,130 per quality-adjusted life year gained, making it a reasonable treatment option.
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
This document summarizes a study on hospital-based health technology assessment (HB HTA) in Italy. The study aimed to assess the diffusion of HB HTA, its impact on hospital decisions, and potential factors influencing its effectiveness. A survey found that almost half of hospitals have an HTA commission. While few clear impacts were identified, some relationships were found between HTA characteristics and resource use. Future research should evaluate additional outcomes to better understand HB HTA's effects and inform its adoption.
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
This document reviews the gap between demand and access to medicines in Brazil's public health care system. It finds that while over 70% of medical consultations are publicly funded, around 70% of medicines are privately purchased due to high prices and limited availability in public pharmacies. This shifts the financial burden to users and disproportionately harms those who cannot afford treatment, increasing inequality. The document calls for improvements in budget forecasting, health planning, and data collection to better measure and address variations in access to medicines across regions and types of treatments.
MAST: a model for HTA-based assessment of telemedicine applications
This document describes MAST (Model for Assessment of Telemedicine), a multidisciplinary framework for assessing telemedicine applications. It was developed through a comprehensive process and aims to describe effectiveness and quality of care impacts of telemedicine. MAST consists of 3 stages: setting context, multidisciplinary assessment across clinical, economic, organizational and social domains, and assessing transferability. It is being empirically tested through large European projects and has supported over 25 trials. While time-consuming, MAST provides a standardized approach and ensures comparability. Feedback has been positive and several regions are adopting it, with revisions planned based on empirical results to establish MAST as a widely accepted methodology.
Decision making in management for large medical equipment
This document discusses decision making for purchasing large medical equipment like MRI machines. It presents data showing differences in MRI availability between countries. There are challenges in decision making due to varying supplier policies, objectives of health facilities, and heterogeneous information. A methodology is proposed to help with rational choice involving developing a system for equipment selection and procurement. Experts would be evaluated and their competence indexed based on both objective and subjective criteria. Analytical hierarchy process (AHP) techniques could be applied to determine priority weights for MRI machine characteristics through pairwise comparisons. Predictions could also be made on how weights may change. This would help create a ranked list of recommended MRI machine options.
Quantifying the clinical benefits of new imaging technologies: A technology a...
Quantifying the clinical benefits of new imaging technologies: A technology assessment of EOS® 2D/3D X-ray imaging system
Representing uncertainty and its consequences in cost-effectiveness analyses
i) A decision to adopt clopidogrel for 12 months (clop12) has a 52.4% chance of being cost-effective but there is significant uncertainty with a 47.6% chance of error.
ii) The expected consequences of this uncertainty are 5,194 QALYs. Alternative scenarios show lower expected consequences ranging from 3,969 QALYs.
iii) Natural history parameters like mortality and relative treatment effect parameters have the greatest influence on decision uncertainty. Conducting research to reduce uncertainty around these parameters could help resolve over 5,000 QALYs of expected decision uncertainty.
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Este documento resume los principales abordajes utilizados para estimar la carga de enfermedad por rotavirus y neumococo en estudios realizados en Latinoamérica. Los dos abordajes más comunes fueron aquellos basados en incidencia o resultados intermedios. La fuente de datos más utilizada fueron estudios publicados y en segundo lugar estadísticas vitales. Se concluye que existe la necesidad de realizar más estudios de carga de enfermedad en la región y que este abordaje propuesto y el manual mencionado pretenden promover y facilitar
Diabetes presentation dr mohammed abuelkhair logo
The document identifies opportunities to enhance prescribing efficiency for diabetes patients in Abu Dhabi, such as increasing the use of generic medications, modified release preparations, and cost-effective agents. It analyzes prescribing trends across different healthcare facilities and recommends strategies to improve quality of care and reduce costs, including promoting evidence-based prescribing of first-line therapies.
Presentation scotland bbg logo
This document analyzes initiatives in Scotland to enhance prescribing efficiency for cardiovascular drugs, proton pump inhibitors, and atypical antipsychotics. It finds that education, economics, and engineering measures successfully increased the use of generic omeprazole, simvastatin, and ACE inhibitors, controlling expenditures. However, the availability of generic risperidone did not increase its use relative to other atypical antipsychotics, limiting potential savings. The analysis suggests multiple demand-side measures are needed across therapeutic classes to maximize efficiency gains from lower-cost generics.
More Related Content
More from HTAi Bilbao 2012
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPTANCE OF TELEMONITORING FOR CHRONIC PATIENTS
Estibalitz Orruño1, Marie-Pierre Gagnon2-3, José Asua4, Eva Reviriego1
1 Basque Office for Health Technology Assessment (Osteba), Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
2 Faculty of Nursing Sciences, Université Laval, Québec, Canada.
3 Research Centre of the Centre Hospitalier Universitaire de Québec, Québec, Canada.
4 Direction of Knowledge Management and Evaluation, Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
On the outside looking in.
The document discusses improving opportunities for patient and consumer engagement in health technology assessment (HTA) in Australia. It notes that while mechanisms exist for patient input, the overall HTA process is not well understood, advocacy groups are under-resourced, and the timeline for submissions is short. It proposes the formation of HTA_AUS, a coalition of interested parties including patient groups, government, industry and others, to address this issue and develop practical solutions like supporting patient submissions and extending deadlines. The coalition aims to increase awareness, education and support for patient engagement in HTA.
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATION: SOLUTIONS DEVELOPED IN THE IFEDH FRAMEWORK
G. Zauner
dwh Simulation Services
Vienna , Austria
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatments in France?
HTAi 2012, Bilbao
Clémence Thébaut, Olivier Scemama, Françoise Hamers, Catherine Rumeau-Pichon
Department of economic and public health evaluation
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual technology decision level part 2
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
The application of Health Technology Assessment in the field of biologics: an...
This document provides a health technology assessment of etanercept for treating rheumatoid arthritis. It includes 7 chapters that evaluate the epidemiology and burden of RA, biologic drugs for RA including etanercept, the economic impacts, organizational implications, and ethical considerations of using etanercept. The assessment finds that etanercept improves quality of life when combined with methotrexate compared to methotrexate alone, and has a cost-effectiveness ratio of €25,130 per quality-adjusted life year gained, making it a reasonable treatment option.
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
This document summarizes a study on hospital-based health technology assessment (HB HTA) in Italy. The study aimed to assess the diffusion of HB HTA, its impact on hospital decisions, and potential factors influencing its effectiveness. A survey found that almost half of hospitals have an HTA commission. While few clear impacts were identified, some relationships were found between HTA characteristics and resource use. Future research should evaluate additional outcomes to better understand HB HTA's effects and inform its adoption.
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
This document reviews the gap between demand and access to medicines in Brazil's public health care system. It finds that while over 70% of medical consultations are publicly funded, around 70% of medicines are privately purchased due to high prices and limited availability in public pharmacies. This shifts the financial burden to users and disproportionately harms those who cannot afford treatment, increasing inequality. The document calls for improvements in budget forecasting, health planning, and data collection to better measure and address variations in access to medicines across regions and types of treatments.
MAST: a model for HTA-based assessment of telemedicine applications
This document describes MAST (Model for Assessment of Telemedicine), a multidisciplinary framework for assessing telemedicine applications. It was developed through a comprehensive process and aims to describe effectiveness and quality of care impacts of telemedicine. MAST consists of 3 stages: setting context, multidisciplinary assessment across clinical, economic, organizational and social domains, and assessing transferability. It is being empirically tested through large European projects and has supported over 25 trials. While time-consuming, MAST provides a standardized approach and ensures comparability. Feedback has been positive and several regions are adopting it, with revisions planned based on empirical results to establish MAST as a widely accepted methodology.
Decision making in management for large medical equipment
This document discusses decision making for purchasing large medical equipment like MRI machines. It presents data showing differences in MRI availability between countries. There are challenges in decision making due to varying supplier policies, objectives of health facilities, and heterogeneous information. A methodology is proposed to help with rational choice involving developing a system for equipment selection and procurement. Experts would be evaluated and their competence indexed based on both objective and subjective criteria. Analytical hierarchy process (AHP) techniques could be applied to determine priority weights for MRI machine characteristics through pairwise comparisons. Predictions could also be made on how weights may change. This would help create a ranked list of recommended MRI machine options.
Quantifying the clinical benefits of new imaging technologies: A technology a...
Quantifying the clinical benefits of new imaging technologies: A technology assessment of EOS® 2D/3D X-ray imaging system
Representing uncertainty and its consequences in cost-effectiveness analyses
i) A decision to adopt clopidogrel for 12 months (clop12) has a 52.4% chance of being cost-effective but there is significant uncertainty with a 47.6% chance of error.
ii) The expected consequences of this uncertainty are 5,194 QALYs. Alternative scenarios show lower expected consequences ranging from 3,969 QALYs.
iii) Natural history parameters like mortality and relative treatment effect parameters have the greatest influence on decision uncertainty. Conducting research to reduce uncertainty around these parameters could help resolve over 5,000 QALYs of expected decision uncertainty.
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Este documento resume los principales abordajes utilizados para estimar la carga de enfermedad por rotavirus y neumococo en estudios realizados en Latinoamérica. Los dos abordajes más comunes fueron aquellos basados en incidencia o resultados intermedios. La fuente de datos más utilizada fueron estudios publicados y en segundo lugar estadísticas vitales. Se concluye que existe la necesidad de realizar más estudios de carga de enfermedad en la región y que este abordaje propuesto y el manual mencionado pretenden promover y facilitar
Diabetes presentation dr mohammed abuelkhair logo
The document identifies opportunities to enhance prescribing efficiency for diabetes patients in Abu Dhabi, such as increasing the use of generic medications, modified release preparations, and cost-effective agents. It analyzes prescribing trends across different healthcare facilities and recommends strategies to improve quality of care and reduce costs, including promoting evidence-based prescribing of first-line therapies.
Presentation scotland bbg logo
This document analyzes initiatives in Scotland to enhance prescribing efficiency for cardiovascular drugs, proton pump inhibitors, and atypical antipsychotics. It finds that education, economics, and engineering measures successfully increased the use of generic omeprazole, simvastatin, and ACE inhibitors, controlling expenditures. However, the availability of generic risperidone did not increase its use relative to other atypical antipsychotics, limiting potential savings. The analysis suggests multiple demand-side measures are needed across therapeutic classes to maximize efficiency gains from lower-cost generics.
More from HTAi Bilbao 2012 (20)
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
MAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applications
Decision making in management for large medical equipment
Decision making in management for large medical equipment
Quantifying the clinical benefits of new imaging technologies: A technology a...
Quantifying the clinical benefits of new imaging technologies: A technology a...
Representing uncertainty and its consequences in cost-effectiveness analyses
Representing uncertainty and its consequences in cost-effectiveness analyses
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo